+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
From
From
Heart Failure - Epidemiology forecast- 2032 - Product Thumbnail Image

Heart Failure - Epidemiology forecast- 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Myocarditis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Myocarditis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hypertrophic Cardiomyopathy (HCM) - Epidemiology forecast- 2032 - Product Thumbnail Image

Hypertrophic Cardiomyopathy (HCM) - Epidemiology forecast- 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Transthyretin Amyloid Cardiomyopathy - Pipeline Inisght, 2021 - Product Thumbnail Image

Transthyretin Amyloid Cardiomyopathy - Pipeline Inisght, 2021

  • Clinical Trials
  • September 2021
  • 60 Pages
  • Global
From
From
Inclisiran - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Inclisiran - Emerging Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Gemcabene - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Gemcabene - Emerging Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Cardiovascular Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cardiovascular Drugs Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Intracranial Aneurysm Market Report and Forecast 2024-2032 - Product Thumbnail Image

Intracranial Aneurysm Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 140 Pages
  • Global
From
Dyslipidemia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Dyslipidemia Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Myocarditis Market Report and Forecast 2024-2032 - Product Thumbnail Image

Myocarditis Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
From
Genetic Cardiomyopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Genetic Cardiomyopathies Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 200 Pages
  • Global
From
Antihyperlipidemic Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Antihyperlipidemic Drugs Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 160 Pages
  • Global
From
From
Heparin Market Report and Forecast 2023-2031 - Product Thumbnail Image

Heparin Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more